First Patient Enrolled in Corindus' Postmarket PRECISION GRX Registry
September 12, 2017—Corindus Vascular Robotics, Inc. announced that the first patient was enrolled in the PRECISION GRX Registry, a postmarket study to continue surveillance of the company's second-generation CorPath GRX system.
